- Clinical outcomes of patients with POLE mutated endometrioid endometrial cancer. Gynecologic Oncology. 2020 Academic Article GET IT
Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade.
Times cited: 3
Measuring toxic effects and time to treatment failure for nivolumab plus ipilimumab in melanoma.
Times cited: 37
Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma.
Times cited: 17
Thinking critically about classifying adverse events: Incidence of pancreatitis in patients treated with nivolumab + ipilimumab.
Journal of the National Cancer Institute.
Times cited: 20
- Patient-Physician Communication in the 21st Century. Trends in Immunology. 2016 Article GET IT
Combinatorial Cancer Immunotherapies.
Advances in Immunology.
Times cited: 42